<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72603-140-02
</NDCCode>
<PackageDescription>
10 VIAL in 1 CARTON (72603-140-02) / 20 mL in 1 VIAL (72603-140-01)
</PackageDescription>
<NDC11Code>
72603-0140-02
</NDC11Code>
<ProductNDC>
72603-140
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Lacosamide
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Lacosamide
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20230313
</StartMarketingDate>
<EndMarketingDate>
20250331
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA209465
</ApplicationNumber>
<LabelerName>
Northstar Rx LLC.
</LabelerName>
<SubstanceName>
LACOSAMIDE
</SubstanceName>
<StrengthNumber>
10
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Decreased Central Nervous System Disorganized Electrical Activity [PE]
</Pharm_Classes>
<DEASchedule>
CV
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-04-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20230313
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20250331
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>